Verve Therapeutics

+$1.23 (+9.10%) As of 3:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERV and other ETFs, options, and stocks.

About VERV

Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines.

CEO
Sekar Kathiresan
Employees
113
Headquarters
Cambridge, Massachusetts
Founded
2018

VERV Key Statistics

Market cap
717.76M
Price-Earnings ratio
—
Dividend yield
—
Average volume
607.74K
High today
$14.75
Low today
$13.28
Open price
$13.50
Volume
133.01K
52 Week high
$78.00
52 Week low
$11.30

VERV Earnings

-$2.13
-$1.42
-$0.71
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure